2022
DOI: 10.5414/cn110808
|View full text |Cite
|
Sign up to set email alerts
|

Potentially inappropriate medication in patients with chronic kidney disease and elderly patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Studies have reported that pharmacists may play a critical role in managing concurrent DKD, because of their unique perspectives on medications prescribed across conditions and providing actionable medication-related recommendations ( Fazel et al, 2017 ; Zullig et al, 2020 ). A few studies have shown that the incidence of potentially inappropriate medication (PIM) is high in older patients with chronic kidney disease (CKD) ( Roux-Marson et al, 2020 ; Luthke et al, 2022 ; Pehlivanli et al, 2022 ; Sharma et al, 2022 ); one has reported that proton pump inhibitors (PPI) were the most common medications induced PIM ( Pehlivanli et al, 2022 ), while others revelled that polypharmacy and reduced estimated glomerular filtration rate (eGFR) were predictors for PIM in this population ( Luthke et al, 2022 ; Sharma et al, 2022 ). There are studies on PIM in older diabetic patients ( Oktora et al, 2021 ), but few studies have explored PIM in older diabetic nephropathy patients in China.…”
Section: Introductionmentioning
confidence: 99%
“…Studies have reported that pharmacists may play a critical role in managing concurrent DKD, because of their unique perspectives on medications prescribed across conditions and providing actionable medication-related recommendations ( Fazel et al, 2017 ; Zullig et al, 2020 ). A few studies have shown that the incidence of potentially inappropriate medication (PIM) is high in older patients with chronic kidney disease (CKD) ( Roux-Marson et al, 2020 ; Luthke et al, 2022 ; Pehlivanli et al, 2022 ; Sharma et al, 2022 ); one has reported that proton pump inhibitors (PPI) were the most common medications induced PIM ( Pehlivanli et al, 2022 ), while others revelled that polypharmacy and reduced estimated glomerular filtration rate (eGFR) were predictors for PIM in this population ( Luthke et al, 2022 ; Sharma et al, 2022 ). There are studies on PIM in older diabetic patients ( Oktora et al, 2021 ), but few studies have explored PIM in older diabetic nephropathy patients in China.…”
Section: Introductionmentioning
confidence: 99%